应用蛋白质组学技术筛选胰腺癌生物标志物的研究进展  

Research progress in screening biomarkers of pancreatic cancer by proteomic techniques

作　　者：刘辉[1] 张海婧[1] 陈国强[1] 吕丽艳[1] 李智立[1] 

机构地区：[1]中国医学科学院中国协和医科大学基础医学研究所,北京市100005

出　　处：《世界华人消化杂志》2007年第14期1628-1633,共6页World Chinese Journal of Digestology

基　　金：北京市自然科学基金;No.7062042~~

摘　　要：胰腺癌是一种十分凶险的恶性肿瘤.胰腺癌早期症状不明显,临床确诊的患者多已处于中晚期,大多失去手术治疗机会.蛋白质组技术的快速发展为研究胰腺癌发病机制、发现早期诊断和预后的生物标志物提供了可能.本文就蛋白质组学技术在胰腺癌细胞系、组织、血清和胰液等方面的应用作一综述.Pancreatic cancer is one kind of devastating diseases. Those patients without nonspecific symptoms at early stage had mostly lost the opporunity of surgical therapy when pancreatic cancer was detected at advanced stage. Rapid growth of proteornic technologies provides possibilities to study etiopathogenesis, and screen early diagnostic and prognosis biomarkers of pancreatic cancer. In this paper, the application of proteomic techniques in cell lines, tissues, serum and pancreatic juice from patients with pancreatic cancer is reviewed briefly.

关 键 词：蛋白质组学 胰腺癌 双向凝胶电泳 质谱 电喷雾电离 基质辅助激光解析电离 

分 类 号：R735.9[医药卫生—肿瘤]